308 related articles for article (PubMed ID: 18720457)
41. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
42. Breast Cancer Treatment: A Review.
Waks AG; Winer EP
JAMA; 2019 Jan; 321(3):288-300. PubMed ID: 30667505
[TBL] [Abstract][Full Text] [Related]
43. Breast cancer.
Harbeck N; Gnant M
Lancet; 2017 Mar; 389(10074):1134-1150. PubMed ID: 27865536
[TBL] [Abstract][Full Text] [Related]
44. Clinical implications of the intrinsic molecular subtypes of breast cancer.
Prat A; Pineda E; Adamo B; Galván P; Fernández A; Gaba L; Díez M; Viladot M; Arance A; Muñoz M
Breast; 2015 Nov; 24 Suppl 2():S26-35. PubMed ID: 26253814
[TBL] [Abstract][Full Text] [Related]
45. Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
Chen Z; Yang J; Li S; Lv M; Shen Y; Wang B; Li P; Yi M; Zhao X; Zhang L; Wang L; Yang J
PLoS One; 2017; 12(9):e0182397. PubMed ID: 28863134
[TBL] [Abstract][Full Text] [Related]
46. Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease.
Thomas M; Kelly ED; Abraham J; Kruse M
Semin Oncol; 2019 Apr; 46(2):121-132. PubMed ID: 31239068
[TBL] [Abstract][Full Text] [Related]
47. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
Ferlay J; Colombet M; Soerjomataram I; Mathers C; Parkin DM; Piñeros M; Znaor A; Bray F
Int J Cancer; 2019 Apr; 144(8):1941-1953. PubMed ID: 30350310
[TBL] [Abstract][Full Text] [Related]
48. Risk Factors and Preventions of Breast Cancer.
Sun YS; Zhao Z; Yang ZN; Xu F; Lu HJ; Zhu ZY; Shi W; Jiang J; Yao PP; Zhu HP
Int J Biol Sci; 2017; 13(11):1387-1397. PubMed ID: 29209143
[TBL] [Abstract][Full Text] [Related]
49. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
; Peto R; Davies C; Godwin J; Gray R; Pan HC; Clarke M; Cutter D; Darby S; McGale P; Taylor C; Wang YC; Bergh J; Di Leo A; Albain K; Swain S; Piccart M; Pritchard K
Lancet; 2012 Feb; 379(9814):432-44. PubMed ID: 22152853
[TBL] [Abstract][Full Text] [Related]
50. Pathology of breast cancer in the last half century.
Solanki M; Visscher D
Hum Pathol; 2020 Jan; 95():137-148. PubMed ID: 31682887
[TBL] [Abstract][Full Text] [Related]
51. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
[TBL] [Abstract][Full Text] [Related]
52. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
53. Protein biomarkers for subtyping breast cancer and implications for future research.
Mueller C; Haymond A; Davis JB; Williams A; Espina V
Expert Rev Proteomics; 2018 Feb; 15(2):131-152. PubMed ID: 29271260
[TBL] [Abstract][Full Text] [Related]
54. Lobular breast cancer: incidence and genetic and non-genetic risk factors.
Dossus L; Benusiglio PR
Breast Cancer Res; 2015 Mar; 17():37. PubMed ID: 25848941
[TBL] [Abstract][Full Text] [Related]
55. Type of breast cancer diagnosis, screening, and survival.
Cedolini C; Bertozzi S; Londero AP; Bernardi S; Seriau L; Concina S; Cattin F; Risaliti A
Clin Breast Cancer; 2014 Aug; 14(4):235-40. PubMed ID: 24703317
[TBL] [Abstract][Full Text] [Related]
56. Clonal evolution in cancer.
Greaves M; Maley CC
Nature; 2012 Jan; 481(7381):306-13. PubMed ID: 22258609
[TBL] [Abstract][Full Text] [Related]
57. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
Goldhirsch A; Wood WC; Coates AS; Gelber RD; Thürlimann B; Senn HJ;
Ann Oncol; 2011 Aug; 22(8):1736-47. PubMed ID: 21709140
[TBL] [Abstract][Full Text] [Related]
58. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy.
Schnitt SJ
Mod Pathol; 2010 May; 23 Suppl 2():S60-4. PubMed ID: 20436504
[TBL] [Abstract][Full Text] [Related]
59. Breast cancer: Biology, biomarkers, and treatments.
Barzaman K; Karami J; Zarei Z; Hosseinzadeh A; Kazemi MH; Moradi-Kalbolandi S; Safari E; Farahmand L
Int Immunopharmacol; 2020 Jul; 84():106535. PubMed ID: 32361569
[TBL] [Abstract][Full Text] [Related]
60. Breast cancer.
Harbeck N; Penault-Llorca F; Cortes J; Gnant M; Houssami N; Poortmans P; Ruddy K; Tsang J; Cardoso F
Nat Rev Dis Primers; 2019 Sep; 5(1):66. PubMed ID: 31548545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
